1999
DOI: 10.1053/plac.1998.0387
|View full text |Cite
|
Sign up to set email alerts
|

An Immunohistochemical Study of Type I Insulin-like Growth Factor Receptors in the Placentae of Pregnancies with Appropriately Grown or Growth Restricted Fetuses

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

4
24
1

Year Published

2000
2000
2015
2015

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 39 publications
(29 citation statements)
references
References 29 publications
4
24
1
Order By: Relevance
“…Increased IGF-1R protein expression in our study contradicts data published for human IUGR [53]. Our data do agree with findings of Abu-Amero et al [43] who reported that with IUGR the term placentae displayed higher levels of IGF2 and IGF1R expression compared with the normal term placentae.…”
Section: Igf Receptorssupporting
confidence: 80%
“…Increased IGF-1R protein expression in our study contradicts data published for human IUGR [53]. Our data do agree with findings of Abu-Amero et al [43] who reported that with IUGR the term placentae displayed higher levels of IGF2 and IGF1R expression compared with the normal term placentae.…”
Section: Igf Receptorssupporting
confidence: 80%
“…In agreement, Nissen et al (2005) increased feed allocation from days 25 to 50 or days 25 to 70 of gestation with resultant increases in maternal IGF-1 concentrations. IGF-1 does not cross the placental barrier (Davenport et al, 1990;Holmes et al, 1999). The lower maternal IGF-1 observed in restricted gilts in the current study did not result in subsequently lower IGF-1 concentrations in offspring.…”
Section: Discussioncontrasting
confidence: 44%
“…The documentation of higher cord blood levels of IGF-1 among Caucasian compared with Asian newborns is concordant with the higher incidence of breast cancer in western compared with eastern Asian populations (Ferlay et al, 2004) and compatible with the role IGF appears to play in breast cancer, at least among premenopausal women (Renehan et al, 2004;Schernhammer et al, 2005). Of note, IGF-1 does not cross the placenta (Holmes et al, 1999) and this was also supported by our data, in which the correlation coefficients Table 2 Percent differences a of cord blood levels of IGF-1, IGF-2, and IGFBP-3 between newborns in Boston, USA (reference) and Shanghai, China IGF ¼ insulin-like growth factor. a Adjusted for maternal age, height and weight gain, parity, duration of gestation, and gender of offspring.…”
Section: Discussionsupporting
confidence: 54%
“…We hypothesised, therefore, that cord blood levels of IGF-1, which does not cross the placenta (Holmes et al, 1999), are higher among Caucasian than among Asian neonates, and that cord blood IGF-1 levels are positively associated with birth size. We evaluated this hypothesis, and also examined the role of IGF-2, a main component of the IGF system in foetal life, by studying cord blood samples from babies born to women in Boston, USA and Shanghai, China.…”
mentioning
confidence: 99%